Calamos Advisors
PAHC icon

Calamos Advisors’s Phibro Animal Health PAHC Stock Holding History

Calamos Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,357
Closed -$628K – 1192
2026
Q1 		$628K Buy
+11,357
New +$541K ﹤0.01% 867
2015
Q2 		– Sell
-8,610
Closed -$305K – 710
2015
Q1 		$305K Buy
+8,610
New +$277K ﹤0.01% 633
2014
Q4 		– Sell
-17,206
Closed -$386K – 675
2014
Q3 		$386K Sell
17,206
-6,494
-27% -$130K ﹤0.01% 609
2014
Q2 		$520K Buy
+23,700
New +$450K ﹤0.01% 599

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Calamos Advisors's PAHC Position: Q2 2026 in Review

Calamos Advisors sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 11,357 shares — an estimated $628K sold.

Calamos Advisors first reported a position in PAHC in Q2 2014 and held it in 4 quarters. The position peaked at $628K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Calamos Advisors reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • Calamos Advisors sold 11,357 Phibro Animal Health shares in Q2 2026, an estimated $628K.
  • Calamos Advisors first reported a position in Phibro Animal Health in Q2 2014 and held it in 4 quarters.
  • Calamos Advisors's Phibro Animal Health position peaked at $628K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.